Chromosome 12p Amplification in Triple-Negative/ <i>BRCA1-</i> Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin SensitivityJorge Gómez‐Miragaya, Eva González‐Suárez, Raúl Tonda et al.|Cancer Research|2019Cited by 19
RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenograftsMarina Ciscar, Eva González‐Suárez|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0